Compare Piramal Healthcare with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs IPCA LABS - Comparison Results

PIRAMAL ENTERPRISES     Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES IPCA LABS PIRAMAL ENTERPRISES/
IPCA LABS
 
P/E (TTM) x 16.8 22.4 75.1% View Chart
P/BV x 1.1 4.3 24.6% View Chart
Dividend Yield % 1.7 0.1 1,535.2%  

Financials

 PIRAMAL ENTERPRISES   IPCA LABS
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-19
IPCA LABS
Mar-18
PIRAMAL ENTERPRISES/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs3,303695 474.9%   
Low Rs1,797400 449.2%   
Sales per share (Unadj.) Rs716.5260.2 275.4%  
Earnings per share (Unadj.) Rs79.719.0 420.1%  
Cash flow per share (Unadj.) Rs107.933.1 326.4%  
Dividends per share (Unadj.) Rs28.001.00 2,800.0%  
Dividend yield (eoy) %1.10.2 601.5%  
Book value per share (Unadj.) Rs1,477.5213.0 693.5%  
Shares outstanding (eoy) m184.45126.20 146.2%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x3.62.1 169.1%   
Avg P/E ratio x32.028.9 110.8%  
P/CF ratio (eoy) x23.616.6 142.6%  
Price / Book Value ratio x1.72.6 67.1%  
Dividend payout %35.15.3 666.5%   
Avg Mkt Cap Rs m470,29269,120 680.4%   
No. of employees `0007.813.3 59.0%   
Total wages/salary Rs m22,5047,359 305.8%   
Avg. sales/employee Rs Th16,899.42,477.4 682.1%   
Avg. wages/employee Rs Th2,877.7555.2 518.3%   
Avg. net profit/employee Rs Th1,879.9180.6 1,040.7%   
INCOME DATA
Net Sales Rs m132,15332,836 402.5%  
Other income Rs m3,128418 748.3%   
Total revenues Rs m135,28133,254 406.8%   
Gross profit Rs m66,2904,505 1,471.5%  
Depreciation Rs m5,2021,777 292.7%   
Interest Rs m44,097240 18,358.6%   
Profit before tax Rs m20,1192,905 692.5%   
Minority Interest Rs m3,1940-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,611511 1,684.9%   
Profit after tax Rs m14,7012,394 614.0%  
Gross profit margin %50.213.7 365.6%  
Effective tax rate %42.817.6 243.3%   
Net profit margin %11.17.3 152.6%  
BALANCE SHEET DATA
Current assets Rs m122,74219,455 630.9%   
Current liabilities Rs m310,81010,076 3,084.7%   
Net working cap to sales %-142.328.6 -498.2%  
Current ratio x0.41.9 20.5%  
Inventory Days Days2398 23.6%  
Debtors Days Days3967 58.0%  
Net fixed assets Rs m116,90420,260 577.0%   
Share capital Rs m369252 146.2%   
"Free" reserves Rs m272,16126,633 1,021.9%   
Net worth Rs m272,53026,886 1,013.7%   
Long term debt Rs m270,1962,340 11,546.4%   
Total assets Rs m856,26141,173 2,079.7%  
Interest coverage x1.513.1 11.1%   
Debt to equity ratio x1.00.1 1,139.1%  
Sales to assets ratio x0.20.8 19.4%   
Return on assets %6.96.4 107.3%  
Return on equity %5.48.9 60.6%  
Return on capital %12.410.8 115.4%  
Exports to sales %047.6 0.0%   
Imports to sales %014.9 0.0%   
Exports (fob) Rs mNA15,642 0.0%   
Imports (cif) Rs mNA4,884 0.0%   
Fx inflow Rs m15,20015,642 97.2%   
Fx outflow Rs m4,8894,884 100.1%   
Net fx Rs m10,31210,759 95.8%   
CASH FLOW
From Operations Rs m-115,9753,411 -3,399.7%  
From Investments Rs m-8,265-1,354 610.4%  
From Financial Activity Rs m107,525-1,304 -8,245.1%  
Net Cashflow Rs m-16,650753 -2,210.6%  

Share Holding

Indian Promoters % 52.9 45.9 115.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.0 11.4 35.1%  
FIIs % 26.6 25.3 105.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 16.5 17.4 94.8%  
Shareholders   93,274 36,892 252.8%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   DR. REDDYS LAB  PFIZER  NATCO PHARMA  AUROBINDO PHARMA  STERLING BIOTECH  

Compare PIRAMAL ENTERPRISES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 334 Points Lower; IT and Telecom Stocks Witness Huge Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their day deep in the red. At the closing bell, the BSE Sensex stood lower by 334 points (down 0.9%).

Related Views on News

PIRAMAL ENTERPRISES Surges by 10%; BSE HEALTHCARE Index Up 1.3% (Market Updates)

Oct 22, 2019 | Updated on Oct 22, 2019

PIRAMAL ENTERPRISES share price has surged by 10% and its current market price is Rs 1,712. The BSE HEALTHCARE is up by 1.3%. The top gainers in the BSE HEALTHCARE Index is PIRAMAL ENTERPRISES (up 10.0%). The top losers are BIOCON (down 0.3%) and ALKEM LABORATORIES (down 0.3%).

ASTRAZENECA PHARMA Surges by 5%; BSE HEALTHCARE Index Up 1.2% (Market Updates)

Oct 22, 2019 | Updated on Oct 22, 2019

ASTRAZENECA PHARMA share price has surged by 5% and its current market price is Rs 2,424. The BSE HEALTHCARE is up by 1.2%. The top gainers in the BSE HEALTHCARE Index are ASTRAZENECA PHARMA (up 5.5%) and PIRAMAL ENTERPRISES (up 7.2%). The top losers are GLENMARK PHARMA (down 0.2%) and SANOFI INDIA (down 0.2%).

IPCA LABS Announces Quarterly Results (1QFY20); Net Profit Up 101.5% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, IPCA LABS has posted a net profit of Rs 1 bn (up 101.5% YoY). Sales on the other hand came in at Rs 10 bn (up 18.4% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Oct 22, 2019 03:37 PM

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 5-YR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS